These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 7720041

  • 1. The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cells.
    Catherino WH, Jordan VC.
    Cancer Lett; 1995 Mar 23; 90(1):35-42. PubMed ID: 7720041
    [Abstract] [Full Text] [Related]

  • 2. A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog.
    Catherino WH, Wolf DM, Jordan VC.
    Mol Endocrinol; 1995 Aug 23; 9(8):1053-63. PubMed ID: 7476979
    [Abstract] [Full Text] [Related]

  • 3. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor.
    Jiang SY, Jordan VC.
    J Natl Cancer Inst; 1992 Apr 15; 84(8):580-91. PubMed ID: 1556769
    [Abstract] [Full Text] [Related]

  • 4. Point mutation of estrogen receptor (ER) in the ligand-binding domain changes the pharmacology of antiestrogens in ER-negative breast cancer cells stably expressing complementary DNAs for ER.
    Jiang SY, Langan-Fahey SM, Stella AL, McCague R, Jordan VC.
    Mol Endocrinol; 1992 Dec 15; 6(12):2167-74. PubMed ID: 1491696
    [Abstract] [Full Text] [Related]

  • 5. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A, Marschke KB, Arnold KE, Berger EM, Fitzgerald P, Mais DE, Allegretto EA.
    Mol Endocrinol; 1999 Mar 15; 13(3):418-30. PubMed ID: 10076999
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
    Vignon F, Lippman ME, Nawata H, Derocq D, Rochefort H.
    Cancer Res; 1984 May 15; 44(5):2084-8. PubMed ID: 6713400
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells.
    Charlier C, Chariot A, Antoine N, Merville MP, Gielen J, Castronovo V.
    Biochem Pharmacol; 1995 Jan 31; 49(3):351-8. PubMed ID: 7857322
    [Abstract] [Full Text] [Related]

  • 11. A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines.
    Vessières A, Corbet C, Heldt JM, Lories N, Jouy N, Laïos I, Leclercq G, Jaouen G, Toillon RA.
    J Inorg Biochem; 2010 May 31; 104(5):503-11. PubMed ID: 20116857
    [Abstract] [Full Text] [Related]

  • 12. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
    Duan R, Porter W, Safe S.
    Endocrinology; 1998 Apr 31; 139(4):1981-90. PubMed ID: 9528985
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells.
    Riggs KA, Wickramasinghe NS, Cochrum RK, Watts MB, Klinge CM.
    Cancer Res; 2006 Oct 15; 66(20):10188-98. PubMed ID: 17047084
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]

  • 18. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE, Franke TF, Moroni M, Mueller S, Morgan E, Iann MC, Winder AD, Reiter R, Wellstein A, Martin MB, Stoica A.
    Oncogene; 2003 Sep 11; 22(39):7998-8011. PubMed ID: 12970748
    [Abstract] [Full Text] [Related]

  • 19. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J, Liu H, Bentrem DJ, Zapf JW, Jordan VC.
    Cancer Res; 2000 Sep 15; 60(18):5097-105. PubMed ID: 11016635
    [Abstract] [Full Text] [Related]

  • 20. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS.
    Mol Endocrinol; 1996 Mar 15; 10(3):230-42. PubMed ID: 8833652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.